Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis.

Karimifar M, Salesi M, Farajzadegan Z.

Adv Biomed Res. 2012;1:30. doi: 10.4103/2277-9175.98156. Epub 2012 Jul 6.

2.

The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.

Serdaroğlu M, Cakirbay H, Değer O, Cengiz S, Kul S.

Rheumatol Int. 2008 Aug;28(10):965-70. doi: 10.1007/s00296-008-0570-3. Epub 2008 Apr 17.

3.

Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody.

Arshadi D, Nikbin B, Shakiba Y, Kiani A, Jamshidi AR, Boroushaki MT.

Int Immunopharmacol. 2013 Nov;17(3):763-7. doi: 10.1016/j.intimp.2013.08.022. Epub 2013 Sep 18.

PMID:
24055018
5.

Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.

Shakiba Y, Koopah S, Jamshidi AR, Amirzargar AA, Massoud A, Kiani A, Nicknam MH, Nazari B, Nikbin B.

Iran J Allergy Asthma Immunol. 2014 Jun;13(3):147-56.

6.

The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.

Liu X, Jia R, Zhao J, Li Z.

J Rheumatol. 2009 Jun;36(6):1136-42. doi: 10.3899/jrheum.080796. Epub 2009 May 15.

PMID:
19447936
7.

Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.

del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E.

Clin Exp Rheumatol. 2006 May-Jun;24(3):281-6.

PMID:
16870095
10.

Anti-cyclic citrullinated peptide antibodies--activity markers in rheumatoid arthritis.

Predeteanu D, Varzaru L, Balanescu A, Bojinca V, Opris D, Vlad V, Berghea F, Abobului M, Constantinescu C, Ionescu R.

J Med Life. 2009 Jan-Mar;2(1):36-41.

11.

Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?

Vanichapuntu M, Phuekfon P, Suwannalai P, Verasertniyom O, Nantiruj K, Janwityanujit S.

Rheumatol Int. 2010 Apr;30(6):755-9. doi: 10.1007/s00296-009-1058-5. Epub 2009 Jul 12.

PMID:
19597732
12.

Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate.

Salesi M, Ghazvini RA, Farajzadegan Z, Karimifar M, Karimzadeh H, Masoumi M, Ebrahimi B.

J Res Pharm Pract. 2012 Oct;1(2):72-6. doi: 10.4103/2279-042X.108374.

13.

Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide.

El-Barbary AM, Kassem EM, El-Sergany MA, Essa SA, Eltomey MA.

J Rheumatol. 2011 May;38(5):828-34. doi: 10.3899/jrheum.101143. Epub 2011 Mar 1.

PMID:
21362765
14.

Evaluation of the rheumatoid factors of the IgG, IgM and IgA isotypes as prognostic parameters for rheumatoid arthritis among Iraqi patients.

Ahmed MM, Obaid Al-Ruhaimi KA, Mohammed SH.

Indian J Pathol Microbiol. 2010 Jul-Sep;53(3):433-8. doi: 10.4103/0377-4929.68265.

15.

Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.

Arvikar SL, Collier DS, Fisher MC, Unizony S, Cohen GL, McHugh G, Kawai T, Strle K, Steere AC.

Arthritis Res Ther. 2013;15(5):R109.

16.

Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection.

Mansour HE, Metwaly KM, Hassan IA, Elshamy HA, Elbeblawy MM.

Clin Med Insights Arthritis Musculoskelet Disord. 2010 May 24;3:33-42.

17.

Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.

Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H, Inanc M.

Clin Rheumatol. 2007 Jan;26(1):17-23. Epub 2006 Mar 15.

PMID:
16538391
18.

Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity.

Zaky DS, El-Nahrery EM.

Int Immunopharmacol. 2016 Feb;31:105-8. doi: 10.1016/j.intimp.2015.12.011. Epub 2015 Dec 19. Review.

PMID:
26709220
19.

HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.

Konda Mohan V, Ganesan N, Gopalakrishnan R, Venkatesan V.

Int J Rheum Dis. 2016 Dec 10. doi: 10.1111/1756-185X.12948. [Epub ahead of print]

PMID:
27943654
20.

Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity.

Li H, Song W, Li Y, Liu Y, Bai J, Li X, Mu F, Wang Y, Zhang F, Su L, Zhang F.

Clin Rheumatol. 2010 Apr;29(4):413-7. doi: 10.1007/s10067-009-1337-2. Epub 2010 Jan 5.

PMID:
20049501

Supplemental Content

Support Center